Product Information

BETAMETHASONE DP AUG 0.05% CRM is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.2126 per GM under NDC 51672131001. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Dec 9, 2003. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Betamethasone Dipropionate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

BETAMETHASONE DP AUG 0.05% CRM

Betamethasone Dipropionate
$0.2126per GM
High Outlier

Strength

.5 mg/g

NDC

51672131001

Classification

Generic

Dosage Form

CREAM, AUGMENTED

Route

TOPICAL

Effective Date

8/19/2026

Active Ingredients

BETAMETHASONE DIPROPIONATE

Approval Type

Generic (ANDA)

FDA Application

ANDA076543

FDA Approved

12/9/2003

TE Code

AB

On Market Since

12/9/2003

Pharmacological Classes

Corticosteroid Hormone Receptor Agonists
Corticosteroid

Price Statistics

The NADAC for BETAMETHASONE DP AUG 0.05% CRM has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 51.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2126 per GM
All-time high$0.5865 (Feb 12, 2014)
All-time low$0.1843 (May 22, 2024)
52-week high$0.2206
52-week low$0.2104
Median price$0.2400
Average price$0.3120
Largest weekly change-27.7% (Oct 17, 2018)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

+0.8%

1M

+0.8%

3M

-1.7%

6M

-3.2%

1Y

+0.3%

3Y

-3.4%

5Y

-5.7%

All

-51.7%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 45% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of BETAMETHASONE DP AUG 0.05% CRM?

The current National Average Drug Acquisition Cost (NADAC) for BETAMETHASONE DP AUG 0.05% CRM, manufactured by Sun Pharmaceutical Industries Inc., is $0.2126 per GM (NDC 51672131001), effective Aug 19, 2026.

How has the price of BETAMETHASONE DP AUG 0.05% CRM changed over time?

Over the history we have for it, the NADAC for BETAMETHASONE DP AUG 0.05% CRM has declined 51.7%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for BETAMETHASONE DP AUG 0.05% CRM?

Since Nov 28, 2013, the NADAC for BETAMETHASONE DP AUG 0.05% CRM has ranged from a low of $0.1843 (May 22, 2024) to a high of $0.5865 (Feb 12, 2014), with a median of $0.2400 per GM.

Are there cheaper alternatives to BETAMETHASONE DP AUG 0.05% CRM?

Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BETAMETHASONE DP AUG 0.05% CRM, is $0.1179 per GM — about 45% below BETAMETHASONE DP AUG 0.05% CRM.

Who manufactures BETAMETHASONE DP AUG 0.05% CRM?

BETAMETHASONE DP AUG 0.05% CRM (NDC 51672131001) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.